Vorumotide
Vorumotide is an immunological agent for active immunization as well as an antineoplastic agent[1].
Product Specifications
CAS Number
935395-34-9
UNSPSC
12352209
Target
Others
Type
Peptides
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vorumotide.html
Solubility
10 mM in DMSO
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC([C@H](CC(N)=O)NC([C@H](CS)NC(CNC([C@@H]2CCCN2)=O)=O)=O)=O)=O)=O)C(N[C@H](C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCSC)C(N[C@H](C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H]([C@H](O)C)C(NCC(O)=O)=O)=O)CC3=CN=CN3)=O)=O)=O)=O)CC4=CN=CN4)=O)=O)=O)=O)CC5=CN=CN5)=O)=O)=O)=O)CC6=CC=CC=C6)=O
Molecular Formula
C114H181N39O29S2
Molecular Weight
2626.03
References & Citations
[1]WHO Drug Informat ion - World Health Organization (WHO) .|[2]WHO Drug Information-World Health Organization (WHO) .
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
044212-AP 200 µL
ZNF383, NT (ZNF383, Zinc finger protein 383) (AP) discontinued
Sign In for Pricing
View Details 32242064 1.0 µg DNA
NTM Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
043320-ML750 100 µL
TSC1, phosphorylated (S561) (Tsc1, Kiaa0243, Hamartin, Tuberous sclerosis 1 protein homolog) (MaxLight 750) discontinued
Sign In for Pricing
View Details 